丸美生物披露2025半年度分配预案：拟10派2.5元

Core Viewpoint - The company announced its semi-annual distribution plan for 2025, proposing a cash dividend of 2.5 yuan per 10 shares, totaling 1 billion yuan, which represents 53.97% of its net profit [3]. Financial Performance - The company reported a revenue of 1.769 billion yuan for the latest half-year, reflecting a year-on-year growth of 30.83% [1]. - The net profit for the same period was 186 million yuan, showing a year-on-year increase of 5.21% [1]. - The basic earnings per share were reported at 0.46 yuan [1]. Dividend Distribution History - The company has a history of dividend distributions since its listing, with the following key data: - 2025.06.30: 10 shares pay 2.5 yuan (total 1 billion yuan, dividend yield 0.61%) [1] - 2024.12.31: 10 shares pay 5 yuan (total 201 million yuan, dividend yield 1.74%) [1] - 2023.12.31: 10 shares pay 5.2 yuan (total 209 million yuan, dividend yield 1.63%) [1] - 2022.12.31: 10 shares pay 2.5 yuan (total 100 million yuan, dividend yield 0.88%) [1] - 2021.12.31: 10 shares pay 1.9 yuan (total 76 million yuan, dividend yield 0.42%) [1] - 2020.12.31: 10 shares pay 3.5 yuan (total 141 million yuan, dividend yield 0.48%) [1] - 2019.12.31: 10 shares pay 3.9 yuan (total 156 million yuan, dividend yield 0.72%) [1] Industry Comparison - In the beauty and personal care sector, the company ranks among eight firms that announced their 2025 semi-annual distribution plans, with the highest cash distribution being from Aimeike at 362 million yuan [2]. - The company's cash distribution of 1 billion yuan places it in a competitive position within the industry, with a dividend yield of 0.61% [4].